Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Katrin Sjølie

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Diabetes Research and Clinical Practice|February 27, 2007
Prospects for angiotensin receptor blockers in diabetic retinopathyAnne Katrin Sjølie
Ugeskrift for Laeger|December 14, 2004
[Retinopathy of prematurity]Anne Katrin Sjølie, Hanne Jensen
Ophthalmology|September 12, 2009
Blindness in a 25-year follow-up of a population-based cohort of Danish type 1 diabetic patientsJakob Grauslund, Anders Green, Anne Katrin Sjølie
Ugeskrift for Laeger|August 21, 2003
[Diabetic retinopathy--new challenges]Jens Nicolai B Larsen, Anne Katrin Sjølie
Ugeskrift for Laeger|June 2, 2011
[Endophthalmitis is an acute disease which threatens the vision]Ulrik Frydkjær-Olsen, Srishamanthi Sriskandarajah, Anne Katrin Sjølie
Acta Ophthalmologica|December 20, 2008
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration in treatment-naive patientsKaren Bjerg Pedersen, Anne Katrin Sjølie, Flemming Møller
Ugeskrift for Laeger|September 6, 2005
[Antiangiogenesis therapy of age-related macular degeneration]Anne Katrin Sjølie, Kelvin Kamp Mortensen, Merete H Hansen
Ugeskrift for Laeger|April 19, 2003
[Improved therapeutic possibilities of age-related macular degeneration. The Danish Society of Ophthalmology]Merete H Hansen, Kelvin Kamp Mortensen, Anne Katrin Sjølie
Acta Ophthalmologica|July 6, 2013
Retinal vascular calibre and response to light exposure and serial imagingTherese von Hanno, Anne Katrin Sjølie, Ellisiv B Mathiesen
Retina (Philadelphia, Pa.)|July 10, 2010
Electrophysiological assessment of retinal function during 6 months of bevacizumab treatment in neovascular age-related macular degenerationKaren Bjerg Pedersen, Flemming Møller, Anne Katrin Sjølie, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Diabetes Research and Clinical Practice|February 27, 2007
Prospects for angiotensin receptor blockers in diabetic retinopathyAnne Katrin Sjølie
Ugeskrift for Laeger|December 14, 2004
[Retinopathy of prematurity]Anne Katrin Sjølie, Hanne Jensen
Ophthalmology|September 12, 2009
Blindness in a 25-year follow-up of a population-based cohort of Danish type 1 diabetic patientsJakob Grauslund, Anders Green, Anne Katrin Sjølie
Ugeskrift for Laeger|August 21, 2003
[Diabetic retinopathy--new challenges]Jens Nicolai B Larsen, Anne Katrin Sjølie
Ugeskrift for Laeger|June 2, 2011
[Endophthalmitis is an acute disease which threatens the vision]Ulrik Frydkjær-Olsen, Srishamanthi Sriskandarajah, Anne Katrin Sjølie
Acta Ophthalmologica|December 20, 2008
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration in treatment-naive patientsKaren Bjerg Pedersen, Anne Katrin Sjølie, Flemming Møller
Ugeskrift for Laeger|September 6, 2005
[Antiangiogenesis therapy of age-related macular degeneration]Anne Katrin Sjølie, Kelvin Kamp Mortensen, Merete H Hansen
Ugeskrift for Laeger|April 19, 2003
[Improved therapeutic possibilities of age-related macular degeneration. The Danish Society of Ophthalmology]Merete H Hansen, Kelvin Kamp Mortensen, Anne Katrin Sjølie
Acta Ophthalmologica|July 6, 2013
Retinal vascular calibre and response to light exposure and serial imagingTherese von Hanno, Anne Katrin Sjølie, Ellisiv B Mathiesen
Retina (Philadelphia, Pa.)|July 10, 2010
Electrophysiological assessment of retinal function during 6 months of bevacizumab treatment in neovascular age-related macular degenerationKaren Bjerg Pedersen, Flemming Møller, Anne Katrin Sjølie, et al.
Pageof 3